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INTRODUCTION 
 
The development of drug resistance in human pathogens 
against commonly used antibiotics and the decline in 
antibiotic discovery have necessitated a search for new 
antimicrobial substances from other sources including 
natural sources from any terrestrial or marine source 
(Sneader, 2005; Sanglard et al., 2009). Marine 
organisms are known to produce different compounds to 
protect themselves against the variety of their own 
pathogens and therefore can be considered as a potential 
source of many classes of antimicrobial substances. 
More than 18,000 natural products, used for different 
purpose, have been mainly isolated from marine 
sponges, jellyfish, sea anemones, corals, bryozoans, 
molluscs, echinoderms, tunicates and crustaceans. 
However, sponges, which are the most primitive 
invertebrates, are considered as the major rich phyla 
with novel bioactive compounds (Blunt et al., 2007). 
 
There is no doubt that sponges contain antimicrobial 
active metabolites localised in their body. More than 
800 antibiotic metabolites have been isolated from 
marine sponges (Torres et al., 2002), and many new 
metabolites are being discovered every year. Although 
none of the discovered metabolites has been developed 
as an antibacterial drug, many are currently under 
clinical investigation. Psammaplin A, which was 
isolated from the sponge Psammaplysilla (Jimenez and 
Crews, 1991), is the first antibacterial metabolite from 
sponges that is going to be commercialised soon (Laport 
et al., 2009).  
 
In fact, sponges that produce antimicrobial metabolites 
always host symbiotic bacteria (Kobayashi and 
Ishibashi, 1993; Thakur and Anil, 2000; Thomas et al., 
2010). In some cases, about 50-60% of the sponge 
biomass is represented by associated microbes (Vacelet 
and Donadey, 1977; Willenz and Hartman, 1989). But, 
there is no proof whether the bioactive metabolites are 
produced by the sponge-associated microorganisms or 
by the sponge itself (Unson and Faulkner, 1993; 
Faulkner et al., 1994; Unson et al., 1994; Brantley et al., 
1995; Bewley et al., 1996; Lin et al., 2001). In other 
words, sponge metabolites could be synthesised by the 
sponge itself (Garson et al., 1992; Pomponi and 
Willoughby, 1994) or it is obtained from other sources. 
The sources are thought to be limited to the symbiotic 
microbes or to the free living microbes in the marine 
environment (Lindquist et al., 2005). 
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Neopetrosia exigua Kirkpatrick belongs to the phylum 
Porifera, the class Demospongia, of the order 
Haploscleridae, and family Petrosiidae. N. exigua is a 
tropical marine sponge, dominant in tropical 
Australasia, Western South Pacific and South East Asia. 
It is brownish in colour and it has encrusting base with 
erect lamellae (Hooper et al., 2000; Cheng et al., 2008). 
N. exigua has received great attention in natural product 
chemistry. The diversity of N. exigua constituents has 
been demonstrated by the continued discovery of novel 
bioactive metabolites. Since 1980’s, more than 24 
metabolites have been isolated from N. exigua (Table 
1). These metabolites have been reported to possess 
variable bio-activities including vasodilation, 
cytotoxicity, antibacteria, and other activities. The 
metabolites isolated from N. exigua showed variation in 
their chemical structures such as alkaloids, quinones, 
and sterols (Roll et al., 1983; Nakagawa and Endo, 
1984; Williams et al., 1998; Orabi et al., 2002; Iwagawa 
et al., 2000; Williams et al., 2002; Cerqueira et al., 
2003).  
 
On the other hand, most of the isolation strategies 
reported from N. exigua were focused on the isolation of 
metabolites from the whole sponge biomass. Only two 
studies isolated novel antimicrobial metabolites from N. 
exigua-associated microbes. One of the isolated 
metabolites is xestodecalactone, which was isolated 
from the fungus Penicillium cf. montanense and this 
metabolite showed antifungal activity (Edrada et al., 
2002). Other isolated metabolite is aspergiones, which 
were isolated from Aspergillus versicolor. Aspergiones 
were reported to possess antibacterial activity (Lin et al., 
2001).  
 
In our previous preliminary screening (Qaralleh et al., 
2010), N. exigua extracts showed promising 
antimicrobial activity. After that, it was hypothesised 
that the antimicrobial metabolites of N. exigua could be 
variable according to their polarity since different 
classes of chemical structures were isolated previously 
from this species.  
 
MATERIAL AND METHODS 
Sampling and Identification 
The marine sponge N. exigua was collected from 
Langkawi Island - Malaysia (6°12ʹ47.01ʺN 
99°44ʹ39.32ʺE) in 2009 at depths of 1-2 m. The 
collected sponge was transported to the lab in an ice box 
containing dry ice. N. exigua materials were cut into 
small pieces and immediately frozen and maintained at -
20°C prior to extraction.  
The identification of N. exigua was carried out by Mr. 
Lim Swee-Cheng (Tropical Marine Science Institute, 
National University of Singapore, Singapore) based on 
skeletal slides and dissociated spicule mounts.  
 
 
Table 1: Bioactive metabolites isolated from N. exigua 
Metabolite Source  Class Bio-activity References 
(+)-Xestospongin A-D Biomass Alkaloids Vasodilation Nakagawa and Endo 
(1984) 
(-)-Araguspongine K and L Biomass Alkaloids Vasodilation Orabi et al., (2002) 
Xestosin A Biomass Alkaloids Not detected Iwagawa et al., 
(2000) 
Motuporamine A- I Biomass Alkaloids Cytotoxicity Williams et al., 
(1998); Williams et 
al., (2002) 
9'-Epi-3β,3'β-
dimethylxestospongin 
Biomass Alkaloids Not detected Li et al., (2011) 
Exiguamine A Biomass Alkaloid  Inhibition of 
indoleamine-2,3-
dioxygenase 
Brastianos et al., 
(2006) 
Halenaquinone Biomass Quinones Antibacterial Roll et al., (1983) 
Exiguaquinol (2)  Biomass Quinones Inhibit Helicobacter 
pylori glutamate 
racemase (Mur I) 
De Almeida Leone 
et al., (2008) 
Clionasterol Biomass Sterols Inhibit human 
complement system 
Cerqueira et al., 
(2003) 
5α,8α-Epidioxy-24α-
ethylcholest-6-en-βb-ol 
Biomass Sterols Inhibit human 
complement system 
Cerqueira et al., 
(2003) 
Metabolites isolated from Xestospongia exigua were included in this table since X. exigua was re-classified as Neopetrosia exigua. 
 
Extraction 
The frozen N. exigua materials were thawed, washed, 
and then freeze dried in order to remove the excess 
amount of water. The freeze dried materials were 
homogenised and extracted three times by absolute 
methanol (MeOH) for 24 h each. The supernatants were 
removed, centrifuged at 10000g, filtred, and collected. 
The MeOH extracts were combined and the solvent was 
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removed by rotary evaporation. The MeOH extract of N. 
exigua biomass was kept in a deep freezer at -20°C until 
it was used. 
Liquid-liquid fractionation 
A sequential gradient partition with different solvents 
was performed to obtain fractions containing 
compounds distributed according to their polarity. 
Briefly, MeOH extract of N. exigua biomass was 
partitioned successively with n-hexane, carbon 
tetrachloride (CCl4), dichloromethane (CH2Cl2), n-
butanol (n-BuOH), and water (Riguera, 1997). After 
evaporating the solvents using a rotary evaporator, the 
crude extracts of each solvent were labelled and stored 
(-20°C) until it was used.    
 
Antimicrobial assays 
Samples preparation 
A sample of 100 mg from each extract was dissolved in 
1 mL methanol-deionised water (4:1). The extract was 
then clarified by filtration through sterile syringe filter 
with 0.2-0.45 µm pore. Finally, the filtered extract was 
stored as aliquots until it was used. 
 
Microbial strains 
Six reference strains of human pathogens were used 
including two Gram-positive strains (Staphylococcus 
aureus ATCC25923 and Bacillus cereus ATCC11778), 
two Gram-negative strains (Pseudomonas aeruginosa 
ATCC27853 and Escherichia coli ATCC35218), and 
two yeast strains (Candida albicans ATCC10231 and 
Cryptococcus neoformans ATCC90112). 
 
Disc diffusion method 
Antimicrobial activities were tested using disc diffusion 
method. Briefly, inoculum containing 10
7
 CFU/mL was 
spread on Mueller-Hinton agar (MHA) plates for 
bacteria and 10
4
 CFU/mL was spread on potato dextrose 
agar (PDA) for yeast. Using sterile forceps, the sterile 
filter papers (6 mm diameter) containing different 
concentrations of the extracts, negative control or 
positive control were laid down on the surface of 
inoculated agar plate. The plates were incubated at 37°C 
for 24 h for the bacteria and at room temperature (18-
20°C) for 24-48 h for the yeast strains. Each sample was 
tested in triplicate and the zone of inhibition was 
measured as millimetre diameter.  
 
Influence of N. exigua fractions on the microbial 
growth curves of Gram-positive bacteria and yeast 
strains: 
The influence on the growth curves was determined by 
using microdilution method. Three fold dilutions were 
prepared from the fractions tested in this study. This 
was performed using 96-well plate and by mixing 30 µL 
of the fractions (stock concentration of 10 mg/mL) with 
270 µL broth media in the first well of each column to 
produce 1000 µg/mL of final concentration. After 
mixing by pipetting, 100 µL from the well containing 
1000 µg/mL extract (first well of each column) was 
carried over into the next well in the same column that 
contained 200 µL broth media. This step was repeated 
to the end of each column of the plate. For each 
fraction, three columns were treated with the assigned 
microbe while the fourth column was used as a blank. In 
each plate, 8-wells filled with the broth media and 
infected with the assigned microbes were used as 
control.  
  
The final microbes inoculum was adjusted to 10
7
 
CFU/mL for bacteria and 10
4
 for the yeasts strains then 
10 µL was added to each test well. The microplates 
were incubated for 12 h at 37°C for bacteria and at room 
temperature for yeasts inside the microplate reader. The 
turbidity of the cultures was taken every 1 h for 12 h as 
indicator of the bacterial growth. The turbidity in each 
well was measured at 600 nm for the bacteria and at 490 
nm for the yeast strains. The turbidity value of blank 
well was subtracted from the turbidity value obtained 
from the treated well for each concentration. The 
growth curves of the tested microbes in absence (normal 
growth) or presence of different concentrations of the 
fractions were depicted using Microsoft Excel 2010. 
 
Determination of Minimum Inhibitory 
Concentration (MIC)  
Further incubation of the cultures (96-well plates) that 
were used in the growth curves experiments was 
performed for 12 h (total 24 h) and the turbidity was 
measured as before. The lowest concentration of 
fraction needed to inhibit the visible growth of a test 
microorganism after 24 h was considered as the MIC.  
 
Determination of Minimum Bactericidal 
Concentration (MBC): 
Minimal bactericidal concentration (MBC) was 
determined by transferring and spreading the treated 
culture broth of the wells containing the concentrations 
of equal to and higher than the MIC on agar plates. The 
lowest concentration of the fraction required to 
completely destroy test microorganism (no growth on 
the agar plate) after incubation at 37 °C for 24 h 
(bacteria) or at room temperature for 48 h (yeasts) was 
reported as MBC. 
 
RESULTS 
N. exigua extract was examined at concentrations of 0.4, 
1, 2, and 2.5 mg/disc against the Gram-positive B. 
cereus and S. aureus, Gram-negative E. coli and P. 
aeruginosa, and the yeast strains C. albicans and C. 
neoformans. Generally, the results showed that the 
MeOH extract of N. exigua biomass exhibited dose-
dependent activity as the inhibition activity of the 
extract increased by increasing the concentration 
(Figure 1).  
Gram-negative bacteria appeared to be insensitive to the 
extract as the maximum inhibition zone observed was 
9.5 mm against E. coli. Meanwhile, P. aeruginosa was 
highly resistant to the extract since no inhibition zone 
was observed even at the highest concentration tested. 
On the contrary, Gram-positive bacteria were in general 
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the most sensitive strains (Figure 2). At all 
concentrations tested, the extract showed remarkable 
inhibition zones. The range of inhibition zones observed 
was between 12.8 and 24.5 mm. Indeed, S. aureus 
(Figure 2D) was less sensitive than B. cereus (Figure 
2A-C), which gave the highest inhibition zone observed 
(24.5 mm). For the yeast strains tested, both C. albicans 
and C. neoformans appeared to be sensitive to N. exigua 
biomass extract (inhibition zones ranging from 8 to 22.8 
mm). However, C. neoformans (inhibition zones 
ranging from 10 to 22.8 mm) was more sensitive than C. 
albicans (inhibition zones ranging from 8 to 19.8 mm).  
 
Antimicrobial activity of N. exigua fractions 
using disc diffusion method  
A sequential gradient partition with solvents of different 
polarities was carried out using n-hexane, CCl4, CH2Cl2, 
n-BuOH, and water. The fractions obtained contain 
compounds distributed according to their polarity.  
Regardless of the concentrations tested, all fractions 
except the CCl4 fraction showed inhibition zones 
against S. aureus and B. cereus (Figures 3A and B; 
Figure 4B). Similar to N. exigua biomass extract, all 
active fractions tested showed dose-dependent 
inhibition activities as the size of inhibition zone 
increased by increasing the concentration. The highest 
antimicrobial activity observed was for CH2Cl2 fraction 
followed by the fractions of n-BuOH, n-hexane, and 
water. The absence of the inhibition zones for the water 
fraction at the lowest concentration tested point to it as 
having the weakest activity (Figure 4G). For the n-
hexane fraction, the highest inhibition zone observed 
was 20.7 mm against S. aureus (Figure 4I) while the 
lowest inhibition zone observed was 0 mm against B. 
cereus. S. aureus (range of inhibition zones observed 
was 14.3 to 20.7 mm) appeared to be more susceptible 
to n-hexane fraction than B. cereus (range of inhibition 
zones observed was 0 to 15.8 mm).  
 
Figure 1: Antimicrobial activities of different concentrations of N. 
exigua extract using disc diffusion method 
 
Both CH2Cl2 and n-BuOH fractions showed remarkable 
inhibition zones even at the lowest concentration tested 
(Figure 3A and B). Both B. cereus and S. aureus were 
sensitive to the CH2Cl2 and n-BuOH fractions but the 
inhibition activity against B. cereus was higher. CH2Cl2 
fraction possessed stronger antimicrobial activity than 
n-BuOH fraction. The range of inhibition zones 
observed for the CH2Cl2 fraction was 23.8 to 28.7 mm 
and 21.3 to 26.7 mm against B. cereus (Figures 4C and 
D) and S. aureus, respectively. On the contrary, the 
ranges of inhibition zones observed for the n-BuOH 
fraction against B. cereus (Figure 4E and F) and S. 
aureus were 17.8 to 23.7 mm and 14.5 to 22 mm, 
respectively.  
Two yeast strains namely C. albicans and C. 
neoformans were used to evaluate the antifungal 
activities of N. exigua fractions (Figure 5). Generally, 
while n-hexane and CCl4 fractions have no antifungal 
activities, fractions of CH2Cl2, n-BuOH and water 
showed variable antifungal activities. Dose-dependent 
activity was also observed for the antifungal activity of 
the active fractions. Although the lowest concentrations 
of the water fraction tested showed no or negligible 
inhibition zones (0 to 8.3 mm), the highest inhibition 
zone observed from the water fraction was 12.7 mm at 
2.5 mg/disc. The presence of inhibition zone of 21.3 
mm and 18.3 mm indicated strong antifungal activities 
of the CH2Cl2 and n-BuOH fractions. It is observed that 
C. neoformans was more susceptible than C. albicans. 
The inhibition zone observed against C. neoformans 
was in the range of 10.3 to 21.3 mm and the range was 
8.7 to 19.5 mm against C. albicans.  
 
Influence of n-hexane, CH2Cl2, and n-BuOH 
fractions on the microbial growth curves 
Fractions that showed maximum antimicrobial activity 
using disc diffusion method were investigated in this 
test. The fractions were tested at different 
concentrations of equal to 1000, 333, 111, 37, 12.3, and 
4.1 µg/mL. The turbidity of the cultures was taken every 
1 h for 12 h as indicator of microbial growth. The 
growth curves of the tested microbes in absence or 
presence of the fractions were depicted in Figures 6 and 
7. The normal growth curves of all tested microbes were 
depicted in the same figures for comparison.  
All microbes tested showed similar lag phase period. 
After 3 h of incubation, the growth showed steady 
increase, thus the starting point of the exponential phase 
was noted for all microbes. Although, S. aureus, C. 
albicans, and C. neoformans tended to enter the 
stationary phase after 7 to 9 h, B. cereus showed no 
stationary phase during the experiment period (12 h). Of 
all concentrations tested, the influence of the fractions 
on the microbes’ growth curves can be divided into two 
categories. First, the concentrations that completely 
inhibited the microbes’ visible growth. Second, the 
concentrations that showed dose-dependent inhibition 
activities. But the effect of the fractions on the lag phase 
was not critical compared to the effects of the fractions 
on the exponential and stationary phases. Therefore, 
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detailed descriptions were given for the influence of 
each fraction according to these points.  
 
 
 
 
 
 
 
 
 
 
Figure 2: Inhibition zones observed from different concentrations of N. exigua biomass extract using 107 CFU of B. cereus and S. aureus. A: B. 
cereus treated with 0.4 and 1 mg/disc, B: B. cereus treated with 2 mg/disc, C: B. cereus treated with 2.5 mg/disc, D: S. aureus treated with 2 and 2.5 
mg/disc. 
 
 
 
  
  
Figure 3: Antimicrobial activities of different concentrations of N. exigua fractions (n-hexane, CCl4, CH2Cl2, n-BuOH, and water) using disc 
diffusion method. The fractions were tested at different concentrations (0.4, 1, 2, 2.5 mg/disc) against B. cereus (A) and S. aureus (B). Data represent 
mean diameter of triplicate of zone of inhibition including the diameter of the disc (6 mm) and expressed as mm±SD. 
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Figure 4: Inhibition zones observed from different concentrations of N. exigua fractions (n-hexane, CCl4, CH2Cl2, n-BuOH, and water) using 10
7 
CFU of B. cereus and S. aureus. A: B. cereus treated with n-hexane fraction (0.4 to 2.5 mg/disc), B: B. cereus treated with CCl4 fraction (0.4 to 2.5 
mg/disc), C: B. cereus treated with CH2Cl2 fraction (1 and 2.5 mg/disc), D: B. cereus treated with CH2Cl2 fraction (0.4 and 2 mg/disc), E: B. cereus 
treated with n-BuOH fraction (0.4 and 1 mg/disc), F: B. cereus treated with n-BuOH fraction (2 and 2.5 mg/disc), G: B. cereus treated with water 
fraction (2 and 2.5 mg/disc), H: S. aureus treated with n-hexane fraction (0.4 and 1 mg/disc), I: S. aureus treated with n-hexane fraction (2 and 2.5 
mg/disc). 
 
  
Figure 5: Antifungal activities of different concentrations of N. exigua fractions (n-hexane, CCl4, CH2Cl2, n-BuOH, and water) using disc diffusion 
method. The fractions were tested at different concentrations (0.4, 1, 2, 2.5 mg/disc) against C. albicans (A) and C. neoformans (B). Data represent 
mean diameter of triplicate of zone of inhibition including the diameter of the disc (6 mm) and expressed as mm±SD. 
 
Influence on the growth curves of B. cereus and S. 
aureus: 
The results showed that the most effective 
concentration of n-hexane fraction was 1000 µg/mL, 
which completely inhibited the visible growth of B. 
cereus and S. aureus.  The concentration of 333 µg/mL 
completely terminated the exponential phase of B. 
cereus in 1 hour while the concentration of 111 µg/mL 
caused early termination of the B. cereus exponential 
phase in 3 h (Figure 6A). Normal growth patterns from 
B. cereus growth curves were detected for all 
concentrations below 111 µg/mL while the growth 
curve of S. aureus at concentration of 4.1 µg/mL 
appeared to be the closest growth curve to the normal 
growth curve over the experiment time period. For S. 
aureus, concentrations below 1000 µg/mL showed 
dose-dependent inhibition activities (Figure 6B). When 
compared to the normal growth curve, the 
concentration of 333 µg/mL led to delayed beginning 
of the exponential phase of S. aureus for about 4 h.  
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For CH2Cl2 fraction, the results showed that the 
concentrations that completely inhibited the visible 
growth of B. cereus were all concentrations of higher 
than 37 µg/mL (Figure 6C). Dose-dependent inhibition 
of B. cereus growth was detected for all concentrations 
below 111 µg/mL. The beginning of exponential phase 
of B. cereus was delayed for 1 hour when it was treated 
with 37 µg/mL while the stationary phase started after 
6 h incubation. On the other hand, visible growth of S. 
aureus was completely inhibited at all concentrations 
higher than 12.3 µg/mL. The growth of S. aureus was 
also inhibited at 12.3 µg/mL but recovery in the 
growth, representing the beginning of exponential 
phase, was observed after 10 h. A 2 h delay in the 
exponential phase of S. aureus was noted when it was 
treated with 4.1 µg/mL CH2Cl2 fraction. 
   
For n-BuOH fraction, all concentrations higher than 37 
µg/mL completely inhibited the visible growth of B. 
cereus and S. aureus. Dose-dependent inhibition 
activity was detected for all concentrations below 111 
µg/mL. When B. cereus was treated with 12.3 and 4.1 
µg/mL, the growth decreased compared to the growth 
of normal cells (Figure 6E). However, the treated B. 
cereus showed normal beginning of exponential phase. 
Moreover, concentration of 37 µg/mL led to the delay 
in the beginning of exponential phase for about 3 h. 
Similar to CH2Cl2 fraction, a recovery in the growth 
was noted after 10 h incubation when S. aureus was 
treated with 37 µg/mL (Figure 6F). A delay in the 
beginning of the exponential phase for 2 h and 1 hour 
was observed when S. aureus was treated with 12.3 
and 4.1 µg/mL, respectively.  
 
Influence on the growth curves of C. albicans and C. 
neoformans 
For CH2Cl2 fraction, the complete inhibition of the 
visible growth of C. albicans and C. neoformans was 
observed at all concentrations higher than 37 µg/mL. A 
sign of growth recovery, after 12 h incubation, was 
observed when C. albicans was treated with 111 
µg/mL (Figure 7A). Dose-dependent inhibition activity 
was observed for all concentrations below 111 µg/mL 
against both C. albicans and C. neoformans (Figure 
7B). All concentrations below 111 µg/mL showed no 
effect on the beginning of the exponential phase while 
the growth steadily increased with no stationary phase 
up to 12 h. Otherwise, the growth of C. albicans 
steadily increased after 9 h, representing the beginning 
of the exponential phase, when it was treated with 37 
µg/mL. 
 
For n-BuOH fraction, the complete inhibition of the 
visible growth of C. albicans and C. neoformans was 
observed at concentrations higher than 111 and 37 
µg/mL (Figure 7D and E), respectively. All 
concentrations below 333 µg/mL and below 111 
µg/mL showed dose-dependent inhibition activity 
against C. albicans and C. neoformans, respectively. 
The concentrations of 111 and 37 µg/mL showed 
remarkable growth inhibition of C. albicans but the 
beginning of the exponential phase was not affected. 
The concentration of 37 µg/mL led to the delay of the 
beginning of the exponential phase of C. neoformans 
for 1 hour. All other concentrations below 37 µg/mL 
showed normal beginning of the exponential phase of 
C. neoformans while no stationary phase was observed.  
 
Minimum Inhibitory Concentration (MIC) and 
Minimum bactericidal concentration (MBC) of N. 
exigua fractions 
MIC is defined as the lowest concentration that inhibits 
the visible growth of the tested microbes after 24 h. 
The results of larger inhibition zones reflect lower 
MICs. As compared to the influence on the growth 
curves, persistent effects of all fractions were observed 
at 12 h and 24 h incubation. The lowest concentrations 
that completely inhibited the visible growth of all 
microbes after 12 h were same even after 24 h.  
 
The lowest MIC (Table 2) observed was 37 μg/mL for 
n-BuOH fraction against S. aureus. The MIC of 
CH2Cl2 fraction against S. aureus was 111 μg/mL. The 
same MICs (111 μg/mL) were observed for CH2Cl2 
and n-BuOH fractions against B. cereus. Meanwhile, 
the lowest MIC indicated against yeasts was 111 
μg/mL for both CH2Cl2 and n-BuOH fractions against 
C. neoformans. The MICs against C. albicans were 
also equal for both fractions, which is 333 μg/mL. 
 
The MBC is defined as the lowest concentration 
required in killing the tested microbe. The MBC was 
performed by culturing the wells, which showed 
complete inhibition of the visible growth, onto agar 
plates. The concentration that showed no colonies (0 
CFU) on the agar plate, after incubation for 24 h for 
bacteria or 48 h for yeasts, was considered as the 
MBC.  
 
The MBCs (Table 2) of all fractions tested were higher 
than the MICs. The exception of this was the MBC of 
CH2Cl2 fraction against S. aureus. The MBC of CH2Cl2 
fraction against S. aureus was equal to its MIC, which 
is 37 μg/mL. Besides, the MBC of n-BuOH fraction 
against S. aureus was 333 μg/mL, which is similar to 
MBCs of CH2Cl2 and n-BuOH fractions against C. 
neoformans. In contrast, all fractions tested against B. 
cereus and C. albicans showed no killing activity up to 
the highest concentration tested (1000 μg/mL).  
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Figure 6: Influence of n-hexane, CH2Cl2 and n-BuOH fractions at low concentrations (1000-4.1 µg/mL) on the growth of Gram-positive bacteria in 
MHB media during 12 h of incubation at 37 °C. A: B. cereus treated with hexane fraction; B: S. aureus treated with hexane fraction; C: B. cereus 
treated with CH2Cl2 fraction; D: S. aureus treated with CH2Cl2 fraction; E: B. cereus treated with n-BuOH fraction; F: S. aureus treated with n-
BuOH fraction. Data represent mean of triplicate of the growth turbidity and expressed as OD600±SD. 
 
 
Table 2: Minimum Inhibitory Concentration (MIC) and Minimum bactericidal concentration (MBC) of N. exigua 
fractions: 
Fraction B. cereus S. aureus C. albicans C. neoformans 
MIC MBC MIC MBC MIC MBC MIC MBC 
n-Hexane 1000 >1000 1000±0.0 >1000 - - - - 
CH2Cl2 111 >1000 37 37 333 >1000 111 333 
n-BuOH 111 >1000 111 333 333 >1000 111 333 
Positive control 20 - 20 - 400 - 300 - 
Data represent mean of triplicates and expressed as μg/mL±SD; -: not determined. 
Positive control: Chloramphenicol or Amphotericin B 
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Figure 7: Influence of CH2Cl2 and n-BuOH fractions at low concentrations (1000-4.1 µg/mL) on the growth of yeast strains in PDB media during 12 
h of incubation at room temperature. A: C. albicans treated with CH2Cl2 fraction, B: C. neoformans treated with CH2Cl2 fraction. C: C. albicans 
treated with n-BuOH fraction, D: C. neoformans treated with n-BuOH fraction. Data represent mean of triplicate of the growth turbidity and 
expressed as OD490±SD. 
 
DISCUSSION 
 
Two methods were used in this study to evaluate the 
antimicrobial activity. The preliminary screening was 
done using disc diffusion method while the most 
accurate potency of the extract was indicated by 
microdilution method. The use of disc diffusion 
method is useful in the initial screening for 
antimicrobial activity (Jenkins et al., 1998). Equally 
important is the advantage of providing the absolute 
value or concentration at which an extract is effective 
against the test microorganism by using microdilution 
method (Koh et al., 2002). Besides, the absence of 
antimicrobial activity in disc diffusion method does not 
necessarily indicate lack of antimicrobial activity. This 
might be due to the rate of diffusion of the extract into 
the agar and the potency of the extract (Kelman et al., 
2006). In microdilution method, the solubility of the 
specific antimicrobial constituents of the extracts might 
be better (Espina et al., 2011). The influence on the 
growth curves is known as the best method in 
evaluation of antimicrobial agents. This method 
provides a descriptive relationship between the tested 
sample and the microbes (Patton et al., 2006; Rufián-
Henares and Morales, 2008). 
 
An attempt was made in this study to investigate the 
origin of the metabolites that represent the 
antimicrobial activity of the marine sponge N. exigua. 
N. exigua-associated bacteria were isolated and 
evaluated in two forms; total associated microbes 
(mixed culture containing all N. exigua associates) and 
N. exigua isolates (pure culture). The results showed 
that the total-associates have no antimicrobial activity 
while only three marine isolates showed negligible 
antimicrobial activity against B. cereus. On the other 
hand, N. exigua biomass extract exhibited potent 
antimicrobial activity. In fact, the presence of even one 
millimetre inhibition zone indicates the presence of 
active metabolites. Therefore, the preliminary 
investigation of the antimicrobial properties of N. 
exigua provided valuable hints about the abundance of 
the active metabolites but not about the origin of the 
active metabolites. Lin et al., (2001) compared the 
secondary metabolites of fungus Aspergillus 
versicolor, which were cultured from N. exigua, with 
those of N. exigua itself. They found that the secondary 
metabolites isolated from the sponge were not from the 
fungus Aspergillus versicolor since they were not 
similar.  
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Faulkner et al., (1994) hypothesised that the sponge, as 
filter-feeder, filtrates and concentrates the active 
metabolites from a microorganism that is abundant in 
the water. Many compounds have been isolated from 
different sources that possess the same or similar 
chemical structures. It is highly possible that the 
pyridoacridine alkaloids, which are isolated from 
sponges, tunicates and coelenterate, are produced by 
microorganisms (Molinski, 1993). Another example is 
renieramycin-type alkaloids, which are isolated from 
Xestospongia sponges. The chemical structure of 
renieramycin is analogous with saframycins and 
safrins, which are isolated from Streptomyces bacterial 
metabolites (Davidson, 1992). 
 
In our previous study (Qaralleh et al., 2011), aqueous 
extract of N. exigua showed higher antimicrobial 
activity than its organic extract. Marine bioactive 
compounds are extremely polar, thus aqueous solutions 
or strongly polar solvents such as methanol must be 
used for extraction (Houssen and Jaspars, 2005; 
Riguera, 1997). But, the aqueous solutions are usually 
avoided since they are highly problematic. Problems 
like bacterial and fungal growth may lead to 
degradation of the active components. Production of 
endotoxins by microbes may also give false results in 
bioassays. Aqueous solutions need high temperature 
for evaporation; the temperature may cause 
degradation of the metabolites and may also induce the 
microbial growth. On the other hand, the presence of 
salts in aqueous extracts makes the process of isolation 
of the metabolites in a pure form more difficult 
(Shimizu, 1985; Shimizu, 1998; Wright, 1998; 
Houssen and Jaspars, 2005). Hence, N. exigua 
metabolites were extracted in this study using 
methanol. 
 
In drug discovery programmes, active natural product 
is extracted from the source, concentrated, fractionated, 
and purified, yielding one or more pure biologically 
active compounds (Koehn, 2008). Further 
pharmacological assays and chemical work should be 
carried out if the pure compound shows novel 
bioactivity (Riguera, 1997). In this report, bio-guided 
isolation to localise the active component of N. exigua 
was conducted according to the recommendation by 
Riguera (1997). A sequential gradient partition with 
different solvents was performed to obtain fractions 
containing compounds distributed according to their 
polarity. The antimicrobial activities of N. exigua 
fractions were then evaluated using disc diffusion and 
microdilution methods. The results showed that the 
active metabolites were present in n-hexane, CH2Cl2, 
n-BuOH, and water fractions. The presence of the 
inhibition activities in these fractions might indicate 
the presence of many active metabolites with varied 
polarities. Such metabolites like alkaloid salts, amino 
acids, polyhydroxy steroids, and saponins are predicted 
to be found in the n-BuOH fraction. The CH2Cl2-
soluble fraction gain compounds of medium polarity 
such as peptides and depsipeptides, while in the n-
hexane and CCl4 fractions, low polarity metabolites 
like hydrocarbons, fatty acids, acetogenins, terpenes, 
and alkaloids could be found (Riguera, 1997; Ebada et 
al., 2008). 
 
The presence of the antimicrobial activity distributed in 
different polarity fractions, is in agreement with many 
previous studies. Galeano and Martínez (2007) 
screened the antimicrobial activity of 24 sponge 
species extracted with different polarity solvents. The 
study revealed the presence of active metabolites 
distributed in methanol, chloroform, and n-hexane 
fractions (Galeano and Martínez, 2007). Similar results 
were obtained by the study conducted by Safaeian et 
al., (2009). According to the study, antimicrobial 
activity was found in different polarity extracts 
(methanol, ethyl acetate, and n-hexane) suggesting the 
presence of diverse active metabolites.  
 
The antimicrobial activities of the relatively polar 
fractions (CH2Cl2 and n-BuOH) in this study showed 
greater potency compared to the n-hexane and water 
fractions. In fact, sponges’ potent antimicrobial 
metabolites are usually found in polar fractions such as 
CH2Cl2 and n-BuOH. However, some antimicrobial 
metabolites have been isolated from low polarity 
fractions such as n-hexane and benzene. Two novel 
anti-tuberculosis parguesterols have been isolated from 
the n-hexane-soluble fraction of the Caribbean sponge, 
Svenzea zeai (Wei et al., 2007). Lakshmi et al., (2010) 
isolated araguspongin C from the n-hexane fraction of 
Haliclona exigua. Araguspongin C possesses 
promising antifungal activity (Lakshmi et al., 2010). 
The benzene extract of Xestospongia exigua has 
yielded pentacyclic polyketide, which possesses 
antimicrobial activity against S. aureus and B. subtilis 
(Roll et al., 1983).  
 
In this study, the antimicrobial activity was evaluated 
using different methods. Generally, dose-dependent 
antimicrobial activities of N. exigua fractions were 
observed. N. exigua CH2Cl2 and n-BuOH fractions 
were the most potent fractions. The effect of CH2Cl2 
and n-BuOH fractions against S. aureus and C. 
neoformans was not only bacteriostatic, but it was also 
bactericidal because it caused death to the microbes. In 
fact, an agent with in vitro bactericidal activity is 
preferable compared to one with only in vitro 
bacteriostatic activity (Pankey and Sabath, 2004). 
Since the n-hexane fraction showed no bactericidal 
activity, the CH2Cl2 and n-BuOH fractions can be 
considered as the optimal fractions to be used in bio-
guided isolation assay since they showed potent 
bactericidal activities. 
 
In all microbes tested, the larger inhibition zone was 
reflected in lower MIC. But B. cereus was more 
susceptible to N. exigua fractions compared to S. 
aureus in the disc diffusion method. In contrast, the 
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influence on the growth curves of B. cereus and the 
MICs revealed different sensitivities to the 
antimicrobial activity. In addition, there was no killing 
action for all fractions tested against B. cereus. 
Notably, clear inhibition zones were detected when N. 
exigua fractions were tested against B. cereus but a 
zone of growth was also observed around the disc. The 
zone of growth was found at concentrations of 1, 2, 
and 2.5 mg/disc but it was absent at concentration of 
equal to 0.4 mg/disc. Therefore, the ability of B. cereus 
to produce endospores under harsh conditions (Saz, 
1970; Fenselau et al., 2008) was assumed to be the 
reason. To confirm this, endospore staining was 
performed for the bacteria obtained from the zone of 
growth (Figure 8, pointer A) and bacteria far from the 
zone of inhibition in the same plate (Figure 8, pointer 
B). As a result, high percentage of the bacteria from the 
zone of growth appeared to be in endospore form 
compared to the bacteria further away from the same 
plate. The presence of endospores was also reflected on 
the MBCs of N. exigua fractions against B. cereus. The 
MBCs of all fractions tested against B. cereus were 
more than 1000 µg/mL.  
 
In agar-based methods like disc diffusion method, the 
metabolites uploaded into the disc diffuse into the agar 
creating a concentration gradient. The concentrations 
of the metabolites decrease when the distance from the 
disc increases. Therefore, the area near the disc 
contains the highest concentration of the metabolites 
(Kiska, 1998; Othman et al., 2011). This may explain 
that the highest concentrations tested (1, 2, and 2.5 
mg/disc) induced sporulation in B. cereus around the 
disc compared to the lowest concentration (0.4 
mg/disc). 
 
The difference between bactericidal and bacteriostatic 
agents is clear according to the in vitro definition 
(Pankey and Sabath, 2004). The pattern of activity, 
indicated by the influence of N. exigua fractions on the 
growth curves, suggests that the fractions tested at 
certain concentrations are bacteriostatic against all 
microbes.  
 
CONCLUSION  
In conclusion, the abundance of the antimicrobial 
metabolites appears to be in the sponge biomass. N. 
exigua biomass extract showed potent antimicrobial 
activity. The potential of antimicrobial activity of N. 
exigua fractions revealed the presence of more than 
one active metabolite. S. aureus was the most 
susceptible microbe evaluated. n-hexane, CH2Cl2, and 
n-BuOH fractions have been selected to be subjected to 
bio-guided isolation using different chromatographic 
techniques in order to isolate the active metabolites.  
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